GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (WBO:ALGN) » Definitions » Cyclically Adjusted PS Ratio

Align Technology (WBO:ALGN) Cyclically Adjusted PS Ratio : 8.17 (As of May. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Align Technology Cyclically Adjusted PS Ratio?

As of today (2024-05-14), Align Technology's current share price is €252.20. Align Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €30.86. Align Technology's Cyclically Adjusted PS Ratio for today is 8.17.

The historical rank and industry rank for Align Technology's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:ALGN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 6.07   Med: 12.71   Max: 38.66
Current: 8.17

During the past years, Align Technology's highest Cyclically Adjusted PS Ratio was 38.66. The lowest was 6.07. And the median was 12.71.

WBO:ALGN's Cyclically Adjusted PS Ratio is ranked worse than
81.47% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.18 vs WBO:ALGN: 8.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Align Technology's adjusted revenue per share data for the three months ended in Mar. 2024 was €12.183. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €30.86 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Align Technology Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Align Technology's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology Cyclically Adjusted PS Ratio Chart

Align Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.17 32.27 29.79 7.69 8.47

Align Technology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.58 11.70 9.70 8.47 9.82

Competitive Comparison of Align Technology's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Align Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Align Technology's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Align Technology's Cyclically Adjusted PS Ratio falls into.



Align Technology Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Align Technology's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=252.20/30.86
=8.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Align Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Align Technology's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.183/129.4194*129.4194
=12.183

Current CPI (Mar. 2024) = 129.4194.

Align Technology Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.721 100.560 2.215
201409 1.797 100.428 2.316
201412 1.969 99.070 2.572
201503 2.237 99.621 2.906
201506 2.293 100.684 2.947
201509 2.281 100.392 2.941
201512 2.598 99.792 3.369
201603 2.636 100.470 3.396
201606 2.949 101.688 3.753
201609 3.047 101.861 3.871
201612 3.416 101.863 4.340
201703 3.559 102.862 4.478
201706 3.887 103.349 4.868
201709 3.952 104.136 4.912
201712 4.339 104.011 5.399
201803 4.341 105.290 5.336
201806 5.151 106.317 6.270
201809 5.322 106.507 6.467
201812 5.808 105.998 7.091
201903 6.021 107.251 7.266
201906 6.597 108.070 7.900
201909 6.908 108.329 8.253
201912 7.383 108.420 8.813
202003 6.309 108.902 7.498
202006 3.972 108.767 4.726
202009 7.873 109.815 9.279
202012 8.608 109.897 10.137
202103 9.419 111.754 10.908
202106 10.535 114.631 11.894
202109 10.860 115.734 12.144
202112 11.457 117.630 12.605
202203 11.159 121.301 11.906
202206 11.677 125.017 12.088
202209 11.494 125.227 11.879
202212 10.949 125.222 11.316
202303 11.424 127.348 11.610
202306 12.062 128.729 12.127
202309 11.711 129.860 11.671
202312 11.586 129.419 11.586
202403 12.183 129.419 12.183

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Align Technology  (WBO:ALGN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Align Technology Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Align Technology's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Align Technology (WBO:ALGN) Business Description

Traded in Other Exchanges
Address
410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.